Rationale for the judicious use of placebos in PAH trials.
White
R James
RJ
Hiremath
Jagdish
J
D002405:Catheterization, Central Venous / Q000009:adverse effects; D018849:Controlled Clinical Trials as Topic / Q000941:ethics*; D019049:Developed Countries; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000523:psychology*; D038622:Internationality; D010919:Placebos / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010919:Placebos; D014665:Vasodilator Agents